Research Archive — Page 114 of 135
-
July 12, 2018
Team explores diabetes drug’s ability to treat RSV infection
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease. -
July 3, 2018
Nominations for Vanderbilt Prize Student Scholar now open for female graduate students in biomedical sciences
Nominations for the Vanderbilt Prize Student Scholar are now open. The deadline is Monday, Aug. 13, 2018, at 5 p.m. -
July 2, 2018
SMAD4 clue to colon cancer
Loss of a gene that is part of the TGF-beta signaling pathway increased inflammation in the colon and was observed in half of human colitis-associated cancers. -
July 2, 2018
Mother knows best
The first demonstration of bacterial DNA in mammalian fetal intestinal tissue suggests that the mother’s microbiome moves into the fetal intestine. -
June 29, 2018
Scavengers “protect” HDL
Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease. -
June 28, 2018
New staph virulence factor
Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections. -
June 14, 2018
Shared genetics may shape treatment options for certain brain disorders
Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting.